Indegene and Microsoft partner to accelerate generative AI adoption in life sciences companies.
Indegene and Microsoft have formed a strategic partnership to help life sciences companies accelerate the adoption of generative AI (GenAI) services. The collaboration aims to co-innovate GenAI services and workflows across commercial, medical, regulatory, and clinical functions, focusing on key use cases like content super app, future-ready medical content value chain, and data management and analytics for clinical trials. This partnership will help global life sciences companies leverage AI for faster innovation at scale.
July 11, 2024
7 Articles